Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway

Nordic Journal of Psychiatry

Volumn 67, Issue 5, 2013, Pages 351-359

  Glenngård, Anna H ^a   Hjelmgren, Jonas ^b   Thomsen, Per Hove ^c   Tvedten, Torbjörn ^d  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b RTI HEALTH SOLUTIONS   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d Centre for Therapy and Supervision   (Norway)

Author keywords

ADHD; Discrete choice experiment; Patient preferences; Willingness to pay

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DENMARK; DISCRETE CHOICE EXPERIMENT; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG MARKETING; DRUG RELEASE; DRUG SAFETY; ECONOMIC EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTICENTER STUDY; NORWAY; PATIENT PREFERENCE; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; STATISTICAL ANALYSIS; SWEDEN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WILLINGNESS TO PAY;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHOICE BEHAVIOR; DENMARK; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; NORWAY; PATIENT PREFERENCE; QUESTIONNAIRES; SWEDEN; YOUNG ADULT;

EID: 84884516056     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2012.748825     Document Type: Article

References (23)

1. World Health Organization (WHO). The ICD-10 classification of mental and behavioural disorders. Geneva: WHO; 1992.
2. Buitelaar JK. Epidemiology of attention-deficit/hyperactivity disorder: What have we learned over the last decade? In: Sandberg S, editor. Hyperactivity disorders. Cambridge: Cambridge University Press; 2002. p. 30-63.
3. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder - First upgrade. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1: 17-30.
4. Sayal K, Taylor E, Beecham J, Byrne P. Pathways to care in children at risk of attention-deficit hyperactivity disorder. Br J Psychiatry 2002; 181: 43-8.
5. Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: The prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 2003; 42: 1203-1211.
6. Medical Products Agency (MPA). Läkemedelsbehandling av ADHD - Ny rekommendation. Stockholm: MPA; 2009.
7. Thomsen PH, Trillingsgaard A, Rasmussen H, Damm D. Referenceprogram for b ø rn og unge med ADHD. Copenhagen: The Danish Association for Child and Adolescent Psychiatry; 2008.
8. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 2000; 39: 1424-31.
9. Apoteket AB. Läkemedelsboken 2007/ 2008. Sundbyberg: AlfaPrint; 2007.
10. Zoëga H, Furu K, Halld ó rsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: A population-based comparison study. Acta Psychiatr Scand 2011; 123: 360-7.
11. Bateman IJ, Carson RT, Day B, Hanemann WM, Hanley N, Hett T, et al. Economic valuation with stated preference techniques - A manual. Cheltenham: Edward Elgar; 2002.
12. Lancaster KJ. A new approach to consumer theory. J Pol Econ 1966; 74: 132-57.
13. Hensher DA. Joint estimation of process and outcome in choice experiments and implications for willingness to pay. J Transport Econ Policy 2008; 42: 297-322.
14. Train, K. Discrete choice methods with simulation. Cambridge: Cambridge University Press; 2003.
15. Train K, Weeks M. (2004). Discrete choice models in preference space and willingness-to-pay space. Cambridge Working Papers in Economics, 0443. Cambridge: Cambridge University; 2004.
16. Hensher, DA, Rose JM, and Green WH. Applied choice analysis - A primer. Cambridge: Cambridge University Pres s; 2005.
17. Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S. Health state utilities for childhood attention deficit/hyperactivity disorder based on parent preferences in the United Kingdom. Med Decis Making 2005; 25: 56-70.
18. Hahn GJ, Shapiro S. A catalogue and computer program for the design and analysis of orthogonal symmetric and asymmetric fractional factorial experiments. New York: General Electric Research and Development Centre; 1966.
19. Hjelmgren J, Anell A. Population preferences and choice of primary care models: A discrete choice experiment in Sweden. Health Policy. 2007; 83: 314-22.
20. Schulpher M, Bryan S, Fry P, de Winter P Payne H, Emberton M. Patients' preferences for management of non-metastatic prostate cancer; Discrete choice experiment. BMJ 2004; 14; 328 :382.
21. Lloyd A, McIntosh E, Williams AE, Kaptein A, Rabe KF. How does patients' quality of life guide their preferences regarding aspects of asthma therapy? A patient-preference study using discrete-choice experiment methodology. Patient 2008; 1: 309-16.
22. Mülbacher AC, Slawik L, Kasper J, Nübling M. patient preferences in adults with ADHD - A discrete choice experiment. Poster presentation at the ISPOR 12th annual European congress, Paris, 24-27 October 2009.
23. Powell SG, Thomsen PH, Frydenberg M, Rasmussen H. Long-term treatment of ADHD with stimulants - A large observational study of real life patients. J Atten Disord 2011; 15: 439-51.